COMMUNIQUÉS West-GlobeNewswire

CAMP4 to Participate in Upcoming Investor Conferences
01/09/2026
WATERTOWN, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting [...]
Lexicon Pharmaceuticals to Participate at Three Upcoming Investor Conferences
01/09/2026
THE WOODLANDS, Texas, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that company management will present at three upcoming investor conferences taking place in New York [...]
Ultragenyx Announces the Publication of a Successful 96-Week Randomized, Placebo-Controlled Trial with Crossover Treatment of GENGLYCOS™ (also known as DTX401) AAV Gene Therapy in GSDIa in The Journal of Inherited Metabolic Disease
01/09/2026
At Week 96, participants across treatment and crossover groups experienced mean reduction in daily cornstarch intake of 61% while maintaining glycemic control, with most participants achieving reduction of at least 50% [...]
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/09/2026
NEEDHAM, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve [...]
BBOT to Participate in Upcoming Investor Healthcare Conferences
01/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today [...]
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
01/09/2026
FREMONT, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today announced the company will be [...]
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/09/2026
CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted one newly- [...]
Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01/09/2026
NEW HAVEN, Conn., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) (“Arvinas” or the “Company”), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation [...]
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
01/09/2026
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to treat and prevent severe allergic [...]
Acquisition of Own Shares
01/09/2026
Mechelen, Belgium; 01 September 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
Adam Ferrari Health Science Scholarship Names Eshaan Verma 2026 Recipient
01/09/2026
IRVINE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- The Ferrari Foundation has named Eshaan Verma as the recipient of the 2026 Adam Ferrari Health Science Scholarship , a $20,000 award supporting students pursuing health [...]
Earth Science Tech, Inc. Announces 2026 Annual Shareholder Meeting Results
01/09/2026
MIAMI, FL, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) ("Earth Science Tech" or the "Company") today announced the voting results from its first Annual Meeting of Stockholders, held virtually [...]
Haypp Group to Participate in Key Global Tobacco and Nicotine Conferences This Fall
01/09/2026
Washington, D.C, USA, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Haypp Group , parent company of U.S. online nicotine pouch retailers Nicokick.com and Northerner.com , today announced that its leadership will participate in [...]
Research Team Wins Heinz Maurer Award for Linking Bacterium to Eczema Barrier Failure
01/09/2026
Using Lipotype's lipidomics platform, scientists map how Staphylococcus hominis affects the skin's lipid environment in atopic dermatitis, opening promising pathways for eczema treatment DRESDEN, Germany, Sept. 01, 2026 [...]
Attelia Expands the International Patient Experience with New Health Tour Mobile App
01/09/2026
The personalised platform brings treatment planning, online consultations, appointments, transfers, real-time support and long-term aftercare into one secure digital journey ANTALYA, Turkiye, Sept. 01, 2026 (GLOBE [...]
New York Plastic Surgical Group Welcomes Two New Surgeons to Its Team
01/09/2026
Garden City, NY, Sept. 01, 2026 (GLOBE NEWSWIRE) -- New York Plastic Surgical Group (NYPS Group), one of the nation's most respected plastic surgery practices, proudly welcomes two new surgeons, Steven Cai, MD , and Ian [...]
Inner Voyage Recovery Center earns The Joint Commission's Gold Seal of Approval following unannounced survey
01/09/2026
Woodstock outpatient program maintains national accreditation for behavioral health care after three-year review cycle Woodstock, GA, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Inner Voyage Recovery Center, an outpatient [...]
BiomX Inc. to Become Tessera Defense and Homeland Security Inc.
01/09/2026
Name change effective September 11, 2026; common stock to trade on the NYSE American under the new symbol “HLSQ” NETANYA, Israel, Sept. 01, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (the “Company”) today [...]
Juniper’s JBS-003 (F-MISO) Program Receives FDA Breakthrough Therapy Designation, Advancing a First-in-Class Hypoxia Tracer Enabling Radiation De-escalation in HPV-Positive Head and Neck Cancer
01/09/2026
BEDMINSTER, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Juniper Biosciences today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to JBS-003 (18F-fluoromisonidazole, [...]

Pages